Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2008-07-22
2008-07-22
Falk, Anne-Marie (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S320100, C424S093100, C424S093200
Reexamination Certificate
active
09011425
ABSTRACT:
The present invention relates, in general, to a methodology for the generation or nonsegmented negative-strand RNA viruses (Pringle, 1991) from cloned deoxyribonucleic acid (cDNA). Such rescued viruses are suitable for use as vaccines, or alternatively, as plasmids in somatic gene therapy applications. The invention also relates to cDNA molecules suitable as tools in this methodology and to helper cell lines allowing the direct rescue of such viruses. Measles virus (MV) is used as a model for other representatives of the Mononegavirales, in particular the family Paramyxoviridae.
REFERENCES:
patent: 5166057 (1992-11-01), Palese et al.
patent: 5240703 (1993-08-01), Cochran
patent: 5840520 (1998-11-01), Clarke et al.
patent: 6033886 (2000-03-01), Conzelmann
patent: 2035386 (1991-01-01), None
patent: 2065245 (1991-03-01), None
patent: 2154023 (2007-04-01), None
patent: A 0440219 (1991-08-01), None
patent: 0702085 (1996-03-01), None
patent: A 0 702 085 (1996-03-01), None
patent: WO 95/03070 (1995-02-01), None
patent: WO 96/34625 (1996-11-01), None
Verma et al. Gene Therapy-Promises, Problems, and Prospects. Nature, vol. 389, pp. 239-242, Sep. 18, 1997.
Eck et al. Gene-Based Therapy. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Edition, Chapter 5, 1996.
Calain et al. (1993) The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J. Virol. 67: 4822-4830.
Kolakofsky et al. (1998) Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J. Virol. 72(2): 891-899.
Tordo et al. (1992) Evolution of negative-stranded RNA genomes. Seminars in Virology 3: 341-357.
Dorland's Illustrated Medical Dictionary (30thEdition, 2003) Philadelphia: W.B. Saunders and Company, pp. 565 and 1414.
Takeda et al. (2000) Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74(14): 6643-6647.
Sidhu M.S. et al., “Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene”, Apr. 20, 1995,Virology, 208(2): 800-807.
Ballart I et al., “Infectious measles virus from cloned cDNA”, 1990, EurMol Biol Organ [EMBO]J, 9(2):379-384 [retracting by Eschle D., et al. (1991) EMBO J, 10(11):3558.
Ballart I et al Retraction of BA 89092782. Infectious Measles Virus from Cloned Complementary DNA. Retracted by Authors Daniel Eschle, et al., (1991) EMBO J, 10(11):3558.
Calain P. et al., “The rule of six, a basic feature for efficient replication of sendai virus defective interfering RNA”, (1993)J of Virology, 67(8):4822-4830.
Willenbrink et al. “Long-term replication of sendai virus defective interfering particle nucleocapsids in stable helper cell lines”, (1994)J of Virology, 68(12):8413-8417.
Wertz G. et al., “Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA” (1994)Proceedings of the Nat'l Ac. Of Sciences of USA. 91:19:8587-8591.
Schnell M. J. et al., “Infectious rabies viruses from cloned cDNA”, (1994)EMBO J, 13(18):4195-4203.
Lawson N.D. et al., “Recombinant vesicular stomatitis viruses from DNA” (1995)Proceedings of the National Academy of Sciences of USA, 92(9):4477-4481.
Whelan S.P. et al., “Efficient Recovery of Infectious Vesicular Stomatitis Virus Entirely from cDNA Clones” (1995)Proc Natl Acad Sci USA. 92(18):8388-8392.
Radecke F. et al., “Rescue of measles viruses from cloned DNA” (1995)EMBO J, 14(23):5773-5784.
Karin Kalin, “Requirements for Amplification of Synthetic Measles Virus and Canine Distemper Virus Subgenomic RNAs”, Inaugural-Dissertation, Zurich 1995.
Calain, P., et al., Molecular cloning of natural paramyxovirus copy-black defective interfering RNAs and their expression from DNA,Virology, 191:62-71 (1992).
Engelhorn, M., et al., Molecular cloning and characterization of a Sendai virus internal delection defective RNA,Journal of General Virology, 74:137-141 (1993).
Enami, M., et al., A measles virus subgenomic RNA: Structure and generation mechanism,Virology171:427-433 (1989).
Harty, R.N., et al., Mutations within noncoding terminal sequences of model RNAs of Sendai virus: Influence on reporter gene expression,Journal of Virology, 69(8):5128-5131 (1995).
Sidhu, M.S., et al., Defective measles virus in human subacute sclerosing panencephalitis brain,Virology, 202:631-641 (1994).
Collins, et al., “Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development,” (Dec. 1995)Proc. Natl. Acad. Sci., vol. 92, pp. 11563-11567.
Deng, et al., “High-efficiency protein synthesis from T7 RNA polymerase transcripts in 3T3 fibroblasts,” (1991),Gene, vol. 109, pp. 193-201.
Garcin, et al., “A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus,”EMBO, (1995) vol. 14, No. 24, pp. 6087-6094.
Lieber, et al., “High level gene expression in mammalian cells by a nuclear T7-phage RNA polymerase,”Nucleic Acids Research, (1989), vol. 17, No. 21, pp. 8485-8493.
Elroy-Stein, et al., “Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells,”Proc. Natl. Acad. Sci., (Sep. 1990), vol. 87, pp. 6743-6747.
Whelan, et al., “Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones,”Proc. Natl. Acad. Sci., (Aug. 1995), vol. 92, pp. 8388-8392.
Whetter, et al., “Analysis of hepatitis A virus translation in a T7 polymerase-expressing cell line,”Arch Virol. (1994, Supp.), vol. 9, pp. 291-298.
Willenbrink, et al. “Long-Term Replication of Sendai Virus Defective Interfering Particle Nucleocapsids in Stable Helper Cell Lines,”Jour. Of Virol.(Dec. 1994), vol. 68, No. 12, pp. 8413-8417.
Wyatt, et al., Replication-Deficient Vaccinia Virus Encoding Bacteriophage T7 RNA Polymerase for Transient Gene Expression in Mammalian Cells,Virology, (1995), vol. 210, pp. 202-205.
Baltimore et al., “Ribonucleic Acid Synthesis of Vesicular Stomatitis Virus, II. An RNA Polymerase in the Virion”, 1970, Proc. Natl. Acd. Sci. 66(2):572-576.
Bricker et al., “Monoclonal Antibodies to the Glycoprotein of Vesicular Stomatitis Virus (New Jersey Serotype): A Method for Preliminary Mapping of Epitopes”, 1987, Virology 161:533-540.
Collins et al., “Rescure of a 7502-Nucleotide (49.3% of Full-Length) Synthetic Analog of Respiratory Syncytial Virus Genomic RNA”, 1993, Virology 195: 252-256.
Collins et al., “Rescure of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene”, 1991, Proc. Natl. Acad. Sci. 88:9663-9667.
Conzelmann et al., “Rescure of Synthetic Genomic RNA Analogs of Rabies Virus by Plasmid-Encoded Proteins”, 1994, J. Virol. 68(2):713-719.
De et al., “Rescure of Synthetic Analogs of Genome RNA of Human Parainfluenza Virus Type 3”, 1993, Virology 196:344-348.
Dimock et al., “Rescue of Synthetic Analogs of Genomic RNA and Replicative-Intermediate RNA of Human Parainfluenza Virus Type 3”, 1993, J. Virol. 67(5):2772-2778.
Enami et al., “Introduction of site-specific mutations into the genome of influenza virus”, 1990, Proc. Natl. Acd. Sci. 87:3802-3805.
Fuerst et al., “Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase”, 1986, Proc. Natl. Acad. Sci. 83:8122-8126.
Gallione et al., “Nucleotide Sequence of a cDNA Clone Encoding the Entire Glycoprotein from the New Jer
Billeter Martin A.
Kälin Karin
Radecke Frank
Schneider Henriette
Spielhofer Pius
Falk Anne-Marie
McDonnell Boehnen & Hulbert & Berghoff LLP
Schweiz Serum & Impfinstitut Bern
LandOfFree
Host cells comprising cDNA corresponding to the antigenome... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Host cells comprising cDNA corresponding to the antigenome..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Host cells comprising cDNA corresponding to the antigenome... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3934450